Literature DB >> 12956401

Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins.

Piotr Religa1, Krzysztof Bojakowski, Zbigniew Gaciong, Johan Thyberg, Ulf Hedin.   

Abstract

Transplant vasculopathy is a key factor behind the late loss of transplanted organs. Since effective treatment is still lacking, a further understanding of the pathology of this process is important. Here, a rat model of aortic allografts was used and analyzed by immunohistochemistry and biochemical tests. Infrarenal aortic segments were transplanted from F344 to Lewis rats and analysed after 1-12 weeks using isografts as controls. After 1 week, endothelial cells gradually disappeared at the graft lumen as shown by von Willebrand factor staining and cellular activation was detected in the adventitia and intima using cellular retinol-binding protein-1 as a marker. Subsequently, proliferating smooth muscle cells, lymphocytes and macrophages accumulated in the intima as indicated by the appearance of staining for cell- and proliferation-specific antigens (smooth muscle alpha-actin, CD45RC, ED1, cyclin D1 and proliferating cell nuclear antigen). After 4-8 weeks, TUNEL- and Fas-positive cells were observed in the media, denoting progressive apoptosis. In parallel, the developing neointima contained increased immunoreactivity for fibronectin and osteopontin. At the end of the observation period, an accumulation of macrophages and calcification was observed in the media and endothelial cells reappeared at the graft surface. The findings demonstrate major cellular and structural changes in the transplanted artery, including activation, proliferation and apoptosis of SMCs, and an altered composition of the extracellular matrix. Possibly, the observed changes in SMC phenotype, cell cycle and apoptosis during development of transplant arteriosclerosis are related to the expression of extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956401

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

Review 1.  The regulation of vascular smooth muscle cell apoptosis.

Authors:  N J McCarthy; M R Bennett
Journal:  Cardiovasc Res       Date:  2000-02       Impact factor: 10.787

Review 2.  Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant.

Authors:  S Sartore; A Chiavegato; E Faggin; R Franch; M Puato; S Ausoni; P Pauletto
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

3.  Does transforming growth factor beta 1 play a role in the pathogenesis of chronic allograft rejection?

Authors:  D M Little; L D Haynes; T Alam; J G Geraghty; H W Sollinger; D A Hullett
Journal:  Transpl Int       Date:  1999       Impact factor: 3.782

Review 4.  The biology of restenosis.

Authors:  C Bauters; J M Isner
Journal:  Prog Cardiovasc Dis       Date:  1997 Sep-Oct       Impact factor: 8.194

Review 5.  Role of endothelial cells in allograft rejection.

Authors:  M L Rose
Journal:  Vasc Med       Date:  1997       Impact factor: 3.239

6.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.

Authors:  T Wada; M D McKee; S Steitz; C M Giachelli
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

7.  Fibronectin promotes cell cycle entry in smooth muscle cells in primary culture.

Authors:  Joy Roy; Phan Kiet Tran; Piotr Religa; Monsur Kazi; Bimma Henderson; Karin Lundmark; Ulf Hedin
Journal:  Exp Cell Res       Date:  2002-02-15       Impact factor: 3.905

Review 8.  Osteopontin: a versatile regulator of inflammation and biomineralization.

Authors:  C M Giachelli; S Steitz
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

9.  Arteriosclerosis in rat aortic allografts: early changes in endothelial integrity and smooth muscle phenotype.

Authors:  K Bojakowski; P Religa; M Bojakowska; U Hedin; Z Gaciong; J Thyberg
Journal:  Transplantation       Date:  2000-07-15       Impact factor: 4.939

10.  LEW-to-F344 carotid artery allografts: analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses.

Authors:  W W Hancock; C Shi; M H Picard; C Bianchi; M E Russell
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

View more
  6 in total

Review 1.  Mechanism of arterial remodeling in chronic allograft vasculopathy.

Authors:  Qichang Zheng; Shanglong Liu; Zifang Song
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

2.  Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.

Authors:  Jakob L Rukov; Eva Gravesen; Maria L Mace; Jacob Hofman-Bang; Jeppe Vinther; Claus B Andersen; Ewa Lewin; Klaus Olgaard
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-06

3.  Egr-1 upregulates OPN through direct binding to its promoter and OPN upregulates Egr-1 via the ERK pathway.

Authors:  Qi-Feng Liu; Hong-Wei Yu; Gui-Nan Liu
Journal:  Mol Cell Biochem       Date:  2009-06-26       Impact factor: 3.396

4.  Complementary effects of multi-protein components on biomineralization in vitro.

Authors:  Xiaolan Ba; Miriam Rafailovich; Yizhi Meng; Nadine Pernodet; Sue Wirick; Helga Füredi-Milhofer; Yi-Xian Qin; Elaine DiMasi
Journal:  J Struct Biol       Date:  2009-12-24       Impact factor: 2.867

5.  RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima.

Authors:  Cecilia Söderberg-Nauclér; Piotr Religa; Monika K Grudzinska; Krzysztof Bojakowski; Joanna Soin; Frank Stassen
Journal:  Herpesviridae       Date:  2010-12-23

6.  Immunological Aspects Involved in the Degeneration of Cryopreserved Arterial Allografts.

Authors:  Mario González-Gay; Rocío López-Martínez; Sara Busto-Suárez; Mariel Estefanía Riedemann-Wistuba; María Ángeles Menéndez-Herrero; Francisco Álvarez-Marcos; Manuel Alonso-Pérez; Rebeca Alonso-Arias
Journal:  Front Surg       Date:  2020-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.